Rhabdomyolysis during therapy with daptomycin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 16705566.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.
Medical subject headings
- Anti-Bacterial Agents
- Daptomycin
- Rhabdomyolysis